Changing epidemiology of pathogens in ICU bacteremia: Should we take the path of least resistance?

Minerva Anestesiologica

Volumn 81, Issue 9, 2015, Pages 940-942

  Opdam, M H ^a   Van Zanten, A R H ^a  

^a GELDERSE VALLEI HOSPITAL   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ASEPSIS; BACTEREMIA; BLOODSTREAM INFECTION; CRITICALLY ILL PATIENT; DISEASE SEVERITY; EDITORIAL; ENTEROBACTERIACEAE; FLUID RESUSCITATION; GRAM NEGATIVE BACTERIUM; GRAM NEGATIVE INFECTION; GRAM NEGATIVE SEPSIS; HUMAN; HYPOTENSION; INTENSIVE CARE; KLEBSIELLA PNEUMONIAE; MORTALITY; MULTIDRUG RESISTANCE; NONHUMAN; RANDOMIZED CONTROLLED TRIAL (TOPIC); SEPSIS; SEPTIC SHOCK; CROSS INFECTION; INTENSIVE CARE UNIT;

ANTI-BACTERIAL AGENTS; BACTEREMIA; CROSS INFECTION; HUMANS; INTENSIVE CARE UNITS;

EID: 84942156200     PISSN: 03759393     EISSN: 18271596     Source Type: Journal    
DOI: None     Document Type: Editorial

References (20)

1. Brun-Buisson C, Meshaka P, Pinton P, Vallet B; EPISEPSIS Study Group. EPISEPSIS: a reappraisal of the epidemiology and outcome of severe sepsis in French intensive care units. Intensive Care Med 2004;30:580-8.
2. Jawad I, Lukšic I, Rafnsson SB. Assessing available information on the burden of sepsis: global estimates of incidence, prevalence and mortality. J Glob Health 2012;2:010404.
3. Angus DC, Van der Poll T. Severe sepsis and septic shock. N Engl J Med 2013;369:840-51.
4. Phua J, Ngerng W, See K, Tay C, Kiong T, Lim H et al. Characteristics and outcomes of culture-negative versus culture-positive severe sepsis. Crit Care 2013;17:R202.
5. Dellinger R P, Levy MM, Rhodes A, Annane D, Gerlach H, Opal SM et al. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012. Crit Care Med 2013;41:580-637.
6. Tabah A, Koulenti D, Laupland K, Misset B, Valles J, Bru-zzi de Carvalho F et al. Characteristics and determinants of outcome of hospital-acquired bloodstream infections in intensive care units: the EUROBACT International Cohort Study. Intensive Care Med 2012;38:1930-45.
7. Kunz AN1, Brook I. Emerging resistant Gram-negative aerobic bacilli in hospital-acquired infections. Chemotherapy 2010;56:492-500.
8. Pronovost P, Needham D, Berenholtz S, Sinopoli D, Chu H, Cosgrove S et al. An intervention to decrease catheter-related bloodstream infections in the ICU. N Engl J Med 2006;355:2725-32.
9. Orsi GB, Giuliano S, Franchi C, Ciorba V, Protano C, Giordano A et al. Changing epidemiology of ICU acquired bloodstream infections over 12 years in an Italian teaching hospital. Minerva Anestesiol 2015;81:980-8.
10. Zilberberg MD, Shorr A F, Micek ST, Vazquez-Guillamet C, Kollef MH. Multi-drug resistance, inappropriate initial antibiotic therapy and mortality in Gram-negative severe sepsis and septic shock: A retrospective cohort study. Critical Care 2014;18:596.
11. Van Zanten AR. Te golden hour of antibiotic administration in severe sepsis: avoid a false start striving for gold. Crit Care Med 2014;42:1931-2.
12. De Smet AM, Kluytmans JA, Cooper BS, Mascini EM, Benus RF, van der Werf TS et al. Decontamination of the digestive tract and oropharynx in ICU patients. N Engl J Med 2009;360:20-31.
13. Johnson L, Grueber S, Schlotzhauer C, Phillips E, Bullock P, Basnett J, Hahn-Cover K. A multifactorial action plan improves hand hygiene adherence and signifcantly reduces central line-associated bloodstream infections. Am J Infect Control 2014;42:1146-51.
14. Gonzales M, Rocher I, Fortin E, Fontela P, Kaouache M, Tremblay C et al. A survey of preventive measures used and their impact on central line-associated bloodstream infections (CLABSI) in intensive care units (SPIN-BACC). BMC Infect Dis 2013;13:562.
15. Hindiyeh MY, Smollan G, Gefen-Halevi S, Mendelson E, Keller N. Molecular detection of antibiotic resistance genes from positive blood cultures. Methods Mol Biol 2015;1237:97-108.
16. Van Zanten AR. Real-time polymerase chain reaction to evaluate antibiotic appropriateness: should we spread the news to multiply it? Crit Care Med 2012;40:2492-3.
17. Vasudevan A, Mukhopadhyay A, Li J, Yuen E, Tambyah P. A prediction tool for nosocomial multi-drug resistant gram-negative bacilli infections in critically ill pa-tients-prospective observational study. BMC Infect Dis 2014;14:615.
18. Neulier C, Birgand G, Ruppé É, Armand-Lefèvre L, Lolom I, Yazdanpanah Y et al. Enterobacteriaceae bacteremia: risk factors for ESBLPE. Med Mal Infect 2014;44:32-8.
19. Brooks BD, Brooks AE. Terapeutic strategies to combat antibiotic resistance. Adv Drug Deliv Rev 2014;S0169-409X(14)00235-X.
20. Van Duijn PJ, Bonten MJ. Antibiotic rotation strategies to reduce antimicrobial resistance in Gram-negative bacteria in European intensive careunits: study protocol for a cluster-randomized crossover controlled trial. Trials 2014;15:277.